Spots Global Cancer Trial Database for bupropion
Every month we try and update this database with for bupropion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment | NCT04634071 | Smoking Cessati... Cancer, Treatme... | Varenicline Bupropion Long-acting nic... Low-intensity c... High-intensity ... No nicotine rep... Nicotine Replac... | 18 Years - | University of Kentucky | |
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects | NCT04457180 | Advanced Solid ... | Apatinib Mesyla... Repaglinide Bupropion | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy | NCT03301207 | Leukemia, Lymph... | Ibrutinib OC: Ethinylestr... Bupropion Midazolam | 18 Years - | Janssen Research & Development, LLC | |
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment | NCT04634071 | Smoking Cessati... Cancer, Treatme... | Varenicline Bupropion Long-acting nic... Low-intensity c... High-intensity ... No nicotine rep... Nicotine Replac... | 18 Years - | University of Kentucky | |
Carcinogenicity Study of Bupropion | NCT01077596 | Depressive Diso... Cancer | Regular bupropi... Regular SSRI (S... Regular TCA (Tr... Regular use of ... | 18 Years - | GlaxoSmithKline | |
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients | NCT01769768 | Advanced Solid ... | LDE225 Wafarin Bupropion | 18 Years - | Novartis | |
Preoperative Smoking Cessation in Patients Undergoing Surgery | NCT05192837 | Smoking Cessati... Smoking Reducti... Surgery--Compli... Surgery Cancer Postoperative C... Perioperative C... Smoking Abdominal Cance... Thoracic Cancer Urologic Cancer Gynecologic Can... Head and Neck C... | Intensive preop... | 18 Years - | Luzerner Kantonsspital | |
Symptom Burden in Head and Neck Cancer | NCT01219673 | Head And Neck C... | Placebo Armodafinil Minocycline Bupropion | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
Carcinogenicity Study of Bupropion | NCT01077596 | Depressive Diso... Cancer | Regular bupropi... Regular SSRI (S... Regular TCA (Tr... Regular use of ... | 18 Years - | GlaxoSmithKline | |
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects | NCT04457180 | Advanced Solid ... | Apatinib Mesyla... Repaglinide Bupropion | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) | NCT01048983 | Non Small Cell ... | Armodafinil Bupropion Minocycline Curcumin Telephone Quest... | 18 Years - 65 Years | M.D. Anderson Cancer Center |